Article
Non-pncA Gene-Mutated but Pyrazinamide-Resistant Mycobacterium tuberculosis: Why Is That?
Journal of clinical microbiology - 1 Jun 2017
Werngren Jim, Alm Erik, Mansjö Mikael
Abstract excerpt
Pyrazinamide (PZA) is a key component for the effective treatment of drug-susceptible and PZA-susceptible multidrug-resistant (MDRPZA-S) tuberculosis (TB). pncA gene mutations are usually detected in a clear majority (>90%) of PZA-resistant strains but obviously not in all. Rapid and reliable PZA drug susceptibility testing (DST) is critical whenever PZA is to be used in a treatment regimen, not least for the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
